JSR Life Sciences’ Integrated Oncology Platform for Biomarker and Companion Diagnostic Development
Wednesday August 21st, 11:00am-13:00pm
Shonan Health Innovation Park 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, C3 building 2F Hall 3
Join the JSR Life Sciences seminar in Japan this August. Register now to learn more from Crown Bioscience and MBL on our model systems and assay platforms, as well as regulatory expertise, for biomarker discovery and companion diagnostic development and commercialization.
Greater preclinical knowledge is needed on patient responder subgroups, and the genetic background behind their response, to improve patient clinical stratification and reduce attrition rates. This knowledge can help in the design of smarter oncology trials and to speed up the development of next-generation cancer therapies and companion diagnostics.
Join our seminar to hear from Dr. Yangzhou Wang, COO, Crown Bioscience and Dr. Hideo Hashimoto, Director of Corporate Planning and Strategy Division, MBL who will introduce our translational oncology expertise, share how pharmaceutical and diagnostic companies can partner in CDx development, and discuss the following case studies:
- How MoA data from preclinical studies guided clinical development of RET-altered cancers
- How PDX mouse clinical trial and bioinformatics analysis offered evidence to support clinical observations Phase III gastric cancer trials
- Identification of a novel gene panel for PD-1 based immunotherapy
- Development and commercialization of RAS & BRAF genetic mutation testing kit for accelerated market access and broad lab adoption for CDx of cetuximab and panitumumab
Reserve Your Seat Now
Attendance is free of charge, on a first come first serve basis, with registration for the event mandatory.